Ranolazine
Product Images NDC 42571-324

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 42571-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ranolazine Lbl A

Label for Ranolazine Extended-Release Tablets 500 mg, manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc. The label includes storage instructions, dosage direction to see package insert, package count of 60 tablets, and multiple barcodes. Revision date and lot coding details are also visible.*

FDA Label Image

Ranolazine Lbl B

Ranolazine Extended-Release Tablets 1000 mg label with a package size of 60 tablets. The label includes storage instructions, manufacturer Micro Labs Limited located in Goa, India, and manufacturing information for Micro Labs USA, Inc. in Somerset, NJ. The label also advises swallowing the tablets whole without crushing, breaking, or chewing.*

FDA Label Image

Structure (Ranolazine Strct)

Chemical structure diagram of Ranolazine showing its molecular framework, including multiple rings, functional groups such as hydroxyl (OH), methoxy (OMe), and amide linkages, represented with standard atomic symbols and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.